DS06652923
DS06652923 is a potent, orally bioavailable small molecule inhibitor targeting EGFR triple mutations. It demonstrates strong in vitro activity with a GI50 of 9.4 nM in Ba/F3-EGFRdel19/T790M/C795S cells and has shown efficacy in vivo by inducing tumor regression in a syngeneic transplantation model, supporting its use in oncology research for resistant NSCLC.
Product Specifications
Field of Research
Cardiovascular Research, Signal Transduction
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
32-7660-50 50 µg
Recombinant Human Triggering Receptor Expressed On Myeloid 2/TREM-2 (C-6His)
Sign In for Pricing
View Details 